Bridge Labs Expansion Coming to Pegagus Park in 2024

by | Feb 13, 2023
The new two-story lab and office building will offer "the first institutional-quality space" in the DFW market, according to marketing materials.
Dallas Biopharma ReCode Therapeutics Closes $80M Series B Round to Expand Drug Pipeline for Respiratory Diseases
by | Oct 21, 2021
The funding, which was co-led by Pfizer Ventures and EcoR1 Capital, will help drive ReCode's therapy programs for primary ciliary dyskinesia and cystic fibrosis into human clinical studies.